Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis.
Uslu S, Gülle S, Sen G, Capar S, Senel S, Dalkılıc E, Akar S, Koca SS, Tufan A, Yazici A, Yilmaz S, Inanc N, Birlik M, Solmaz D, Cefle A, Goker B, Direskeneli H, Yolbas S, Steen Krogh N, Yilmaz N, Erten S, Bes C, Soysal Gündüz O, Oztürk MA, Haznedaroglu S, Yavuz S, Onen F, Sari I. Uslu S, et al. Among authors: soysal gunduz o. J Clin Med. 2024 Nov 29;13(23):7266. doi: 10.3390/jcm13237266. J Clin Med. 2024. PMID: 39685726 Free PMC article.
Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results.
Uslu S, Gülle S, Urak Ö, Şen G, Dalkılıç E, Şenel S, Akar S, İnanç N, Cefle A, Köken Avşar A, Yolbaş S, Yılmaz S, Soysal Gündüz Ö, Sarı İ, Birlik M, Akkoç N, Önen F. Uslu S, et al. Among authors: soysal gunduz o. Arch Rheumatol. 2024 Mar 20;39(2):232-241. doi: 10.46497/ArchRheumatol.2024.10391. eCollection 2024 Jun. Arch Rheumatol. 2024. PMID: 38933720 Free PMC article.
Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study.
Uslu S, Gulle S, Sen G, Cefle A, Yilmaz S, Kocaer SB, Yuce Inel T, Koca SS, Yolbas S, Ozturk MA, Senel S, Inanc N, Dalkilic HE, Soysal Gunduz O, Tufan A, Akar S, Birlik AM, Sari I, Akkoc N, Onen F. Uslu S, et al. Among authors: soysal gunduz o. Sci Rep. 2024 Jun 20;14(1):14194. doi: 10.1038/s41598-024-65180-4. Sci Rep. 2024. PMID: 38902436 Free PMC article.
Salt-and-pepper appearance of the skin in systemic sclerosis.
Tasgöz FC, Ali Acar E, Kaçar M, Soysal Gündüz Ö, Uslu S. Tasgöz FC, et al. Among authors: soysal gunduz o. Med Clin (Barc). 2024 Jul 26;163(2):e15. doi: 10.1016/j.medcli.2023.11.028. Epub 2024 Mar 27. Med Clin (Barc). 2024. PMID: 38538429 English, Spanish. No abstract available.
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib.
Inanc N, Abacar KY, Ozturk MA, Tufan A, Karadeniz H, Sari I, Can G, Erez Y, Pehlivan Y, Dalkilic HE, Ocak T, Cefle A, Yazici A, Senel AS, Akar S, Durak-Ediboğlu E, Koca SS, Piskin-Sagir R, Yilmaz S, Gulcemal S, Soysal-Gunduz O, Basibuyuk CS, Alkan S, Cesur TY, Onen F. Inanc N, et al. Among authors: soysal gunduz o. J Clin Rheumatol. 2023 Dec 1;29(8):365-369. doi: 10.1097/RHU.0000000000002026. Epub 2023 Sep 19. J Clin Rheumatol. 2023. PMID: 37724891 Free PMC article.
A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry.
Yazici A, Özdemir Işık Ö, Dalkılıç E, Koca SS, Pehlivan Y, Şenel S, Inanc N, Akar S, Yılmaz S, Soysal Gündüz Ö, Cefle A, Karakaş ÖF, Onen F. Yazici A, et al. Among authors: soysal gunduz o. Sci Rep. 2022 Dec 20;12(1):21972. doi: 10.1038/s41598-022-26106-0. Sci Rep. 2022. PMID: 36539458 Free PMC article.